LYMPHOQUANT
Live / Registered — Registered (as of 01 Jun 2021)
What this means for you
Registered since 01 Jun 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87588377
- Registration number
- 6373233
- Mark type
- Stylized text
- Filed
- 29 Aug 2017
- Published for opposition
- 30 Jan 2018
- Registered
- 01 Jun 2021
- Attorney of record
- Sarah W. Matthews
Goods and services
- Class 001 — Chemicals: Reagents for scientific and research use, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for research, clinical research, and laboratory research use
- Class 005 — Pharmaceuticals: Assays for the treatment or diagnosis of disease; medical diagnostic reagents, namely, buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic kits comprised of buffer solutions, enzymes, molecular probes, DNA and RNA polymerases, nucleic acids, nucleic acid derivatives, primers for use in PCR, DNA templates, RNA templates, dyes and biotechnology reagents and solvents for sample preparation, purification, lysis, modification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatment, monitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for testing of bodily fluids
- Class 042 — Scientific and technological services: DNA analysis services for scientific research purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
- Class 044 — Medical, beauty and agricultural services: DNA screening for medical purposes, namely, DNA sequencing, bioinformatics analysis, and interpretation of biological DNA data generated from reagents and assays
Owner
- INVIVOSCRIBE, INC., SAN DIEGO, CA, US
- INVIVOSCRIBE, INC., SAN DIEGO, CA, US
- Invivoscribe Technologies, Inc., San Diego, CA, US
- Invivoscribe Technologies, Inc., San Diego, CA, US
Prosecution history
- 10 Oct 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Oct 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Oct 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 01 Jun 2021 — REGISTERED-PRINCIPAL REGISTER
- 28 Apr 2021 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Apr 2021 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Apr 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Mar 2021 — USE AMENDMENT FILED
- 26 Apr 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Mar 2021 — TEAS STATEMENT OF USE RECEIVED
- 02 Oct 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Oct 2020 — SOU EXTENSION 5 GRANTED
- 24 Sept 2020 — SOU EXTENSION 5 FILED
- 30 Sept 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Sept 2020 — SOU TEAS EXTENSION RECEIVED